CD107a+ (LAMP-1) Cytotoxic CD8+ T-Cells in Lupus Nephritis Patients

Cytotoxic CD8+ T-cells play a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE). The aim of this study was to investigate the role of CD107a (LAMP-1) on cytotoxic CD8+ T-cells in SLE-patients in particular with lupus nephritis. Peripheral blood of SLE-patients (n = 31) and healthy controls (n = 21) was analyzed for the expression of CD314 and CD107a by flow cytometry. Kidney biopsies of lupus nephritis patients were investigated for the presence of CD8+ and C107a+ cells by immunohistochemistry and immunofluorescence staining. The percentages of CD107a+ on CD8+ T-cells were significantly decreased in SLE-patients as compared to healthy controls (40.2 ± 18.5% vs. 47.9 ± 15.0%, p = 0.02). This was even more significant in SLE-patients with inactive disease. There was a significant correlation between the percentages of CD107a+CD8+ T-cells and SLEDAI. The evaluation of lupus nephritis biopsies showed a significant number of CD107a+CD8+ T-cells mainly located in the peritubular infiltrates. The intrarenal expression of CD107a+ was significantly correlated with proteinuria. These results demonstrate that CD8+ T-cells of patients with systemic lupus erythematosus have an altered expression of CD107a which seems to be associated with disease activity. The proof of intrarenal CD107a+CD8+ suggests a role in the pathogenesis of lupus nephritis.

[1]  D. U. Nagy,et al.  Investigation of the PD-1 and PD-L1 Immune Checkpoint Molecules Throughout Healthy Human Pregnancy and in Nonpregnant Women , 2020, Journal of clinical medicine.

[2]  A. Kribben,et al.  BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease , 2019, International journal of molecular sciences.

[3]  O. Witzke,et al.  Th17 cells in renal inflammation and autoimmunity. , 2019, Autoimmunity reviews.

[4]  Andreas Radbruch,et al.  Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages , 2017, European journal of immunology.

[5]  G. Tsokos,et al.  Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4–Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus , 2016, Arthritis & rheumatology.

[6]  K. McFann,et al.  Podocytes Degrade Endocytosed Albumin Primarily in Lysosomes , 2014, PloS one.

[7]  A. Karras,et al.  Tissue-Specific Microvascular Endothelial Cells Show Distinct Capacity To Activate NK Cells: Implications for the Pathophysiology of Granulomatosis with Polyangiitis , 2014, The Journal of Immunology.

[8]  P. Saftig,et al.  Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. , 2013, Blood.

[9]  J. Coligan,et al.  LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. , 2013, Blood.

[10]  M. V. van Dijk,et al.  Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis , 2013, Arthritis Research & Therapy.

[11]  M. Bijl,et al.  Treatment of lupus nephritis , 2010, Expert review of clinical immunology.

[12]  C. Kallenberg,et al.  Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus , 2010, Arthritis research & therapy.

[13]  M. V. van Dijk,et al.  Urinary T cells in active lupus nephritis show an effector memory phenotype , 2010, Annals of the rheumatic diseases.

[14]  C. Combe,et al.  Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. , 2007, Arthritis and rheumatism.

[15]  H. Tsuji,et al.  Disruptive effect of chloroquine on lysosomes in cultured rat hepatocytes. , 2005, Biological & pharmaceutical bulletin.

[16]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[17]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[18]  R. Holcombe,et al.  Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. , 1996, Cellular immunology.

[19]  R. Holcombe,et al.  Correlation of Serum Interleukin-8 and Cell Surface Lysosome-associated Membrane Protein with Clinical Disease Activity in Systemic Lupus Erythematosus , 1994 .

[20]  D. Boumpas,et al.  Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. , 1994, Kidney international.

[21]  M. Liang,et al.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[22]  V. D’Agati,et al.  Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. , 1986, Kidney international.

[23]  A. Elia,et al.  Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndrome. , 2012, Clinical and experimental rheumatology.

[24]  E. Aktas,et al.  Relationship between CD107a expression and cytotoxic activity. , 2009, Cellular immunology.

[25]  J. Moreau,et al.  Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[26]  R. Holcombe,et al.  Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus. , 1994, Lupus.